A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

BACKGROUND: Home-based (unsupervised) buprenorphine initiation is considered safe and effective, yet many patients report barriers to successful treatment initiation. Prescription digital therapeutics (PDTs) are software-based disease treatments regulated by the US Food and Drug Administration (FDA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Luderer, Hilary, Enman, Nicole, Gerwien, Robert, Braun, Stephen, McStocker, Samantha, Xiong, Xiaorui, Koebele, Carrington, Cannon, Christopher, Glass, Joseph, Maricich, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898828/
https://www.ncbi.nlm.nih.gov/pubmed/36662568
http://dx.doi.org/10.2196/43122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898828/
https://www.ncbi.nlm.nih.gov/pubmed/36662568
http://dx.doi.org/10.2196/43122

Ejemplares similares